VRAX logo

VRAX Cash From Investing

Annual CFI

-$1.16 M
-$986.00 K-552.69%

March 1, 2024


Summary


Performance

VRAX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRAXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

VRAX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-552.7%--
3 y3 years---
5 y5 years---

VRAX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%at low
5 y5-year<-9999.0%at low
alltimeall time<-9999.0%at low

Virax Biolabs Group Limited Cash From Investing History

DateAnnualQuarterlyTTM
Mar 2024
-$1.16 M(+552.7%)
-
-
DateAnnualQuarterlyTTM
Mar 2023
-$178.40 K(<-9900.0%)
-
-
Mar 2022
$0.00
-
-

FAQ

  • What is Virax Biolabs Group Limited annual cash flow from investing activities?
  • What is the all time high annual CFI for Virax Biolabs Group Limited?
  • What is Virax Biolabs Group Limited annual CFI year-on-year change?

What is Virax Biolabs Group Limited annual cash flow from investing activities?

The current annual CFI of VRAX is -$1.16 M

What is the all time high annual CFI for Virax Biolabs Group Limited?

Virax Biolabs Group Limited all-time high annual cash flow from investing activities is $0.00

What is Virax Biolabs Group Limited annual CFI year-on-year change?

Over the past year, VRAX annual cash flow from investing activities has changed by -$986.00 K (-552.69%)